Victory Capital Management Inc Pa Vmed Inc. Transaction History

Victory Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$0.22 - $0.5 $183 - $416	832 Added 8.17%	11,019 $3,000
Q2 2023 Jul 27, 2023	BUY	$0.35 - $0.56 $3,565 - $5,704	10,187 New	10,187 $4,000
Q2 2022 Aug 01, 2022	BUY	$0.85 - $1.41 $465 - $772	548 Added 4.9%	11,742 $11,000
Q1 2022 May 04, 2022	SELL	$1.16 - $2.5 $1,111 - $2,395	-958 Reduced 7.88%	11,194 $14,000
Q4 2021 Feb 07, 2022	BUY	$2.46 - $8.74 $1,741 - $6,187	708 Added 6.19%	12,152 $30,000
Q3 2021 Nov 02, 2021	SELL	$5.1 - $9.39 $5,661 - $10,422	-1,110 Reduced 8.84%	11,444 $98,000
Q2 2021 Aug 03, 2021	SELL	$3.95 - $6.88 $201 - $350	-51 Reduced 0.4%	12,554 $80,000
Q1 2021 May 04, 2021	BUY	$2.01 - $5.55 $25,336 - $69,957	12,605 New	12,605 $56,000
Q2 2020 Aug 07, 2020	SELL	$1.75 - $2.65 $8,897 - $13,472	-5,084 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.15 - $3.29 $364 - $1,042	-317 Reduced 5.87%	5,084 $10,000
Q4 2019 Feb 04, 2020	BUY	$0.84 - $1.2 $932 - $1,332	1,110 Added 25.87%	5,401 $8,000
Q3 2019 Nov 12, 2019	BUY	$0.95 - $1.11 $4,076 - $4,763	4,291 New	4,291 $4,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.